AcelRx Pharmaceuticals
ACRX
#9650
Rank
NZ$24.24 M
Marketcap
$1.43
Share price
7.50%
Change (1 day)
39.20%
Change (1 year)

Revenue for AcelRx Pharmaceuticals (ACRX)

Revenue in 2023 (TTM): NZ$1.05 Million

According to AcelRx Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is NZ$1.08 Million. In 2022 the company made a revenue of NZ$0.39 Million a decrease over the revenue in the year 2021 that were of NZ$4.12 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AcelRx Pharmaceuticals from 2010 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) NZ$1.05 M166.19%
2022 NZ$0.39 M-90.38%
2021 NZ$4.12 M-45.04%
2020 NZ$7.5 M120.85%
2019 NZ$3.39 M5.99%
2018 NZ$3.2 M-71.51%
2017 NZ$11.25 M-55.07%
2016 NZ$25.05 M-10.97%
2015 NZ$28.14 M322.7%
2014 NZ$6.65 M-81.45%
2013 NZ$35.9 M1133.65%
2012 NZ$2.91 M111.87%
2011 NZ$1.37 M
2010 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$18.28 M 1,589.09%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.12 B 11,476.04%๐Ÿ‡บ๐Ÿ‡ธ USA